October Deal Frenzy: Biotech Giants Strike Billion-Dollar Partnerships and Pave New R&D Paths 1 year ago ByJohnIn BreakthroughsDealsPartnershipsPharma Industry UpdatesTop Stories
KSQ Therapeutics Receives FDA Clearance to Advance CRISPR-Edited Cell Therapy for Advanced Solid Tumors 1 year ago ByJohnIn Biopharma HighlightsBreakthroughsClinical TrialsFDA ApprovalsTop Stories
FDA Advisory Panel Recommends Sarepta’s Gene Therapy for Duchenne Muscular Dystrophy 1 year ago ByJohnIn Biopharma HighlightsFDA ApprovalsResearch UpdatesTop Stories
US Biotech Faces VC Slowdown, but Startups Adapt with New Strategies 1 year ago ByJohnIn Biopharma HighlightsFunding RoundsTop StoriesVenture Capital
Vertex and CRISPR Therapeutics Secure First-Ever FDA Approval for CRISPR-Based Therapy in Sickle Cell Disease 1 year ago ByJohnIn Biopharma HighlightsFDA ApprovalsResearch UpdatesTop Stories
Griffith University Launches $14M Clinical Trial for Spinal Cord Injury Using Nasal Cell Transplants 1 year ago ByJohnIn Clinical Trials
Replicor Secures $180M Series C to Expand RNA Amplification Platform Beyond Hepatitis B 1 year ago ByJohnIn Pharma Industry UpdatesTop StoriesVenture Capital
FDA Grants RMAT Designation to ExoGene’s Exosome-Based Gene Therapy for ALS 1 year ago ByJohnIn FDA ApprovalsInvestmentsPharma Industry Updates
mRNA-4157/V940 Shows Durable Response in Melanoma: Moderna and Merck’s Cancer Vaccine Hits Key Milestone 2 years ago ByJohnIn Clinical TrialsPharma Industry Updates
